Patents by Inventor Heinz Moeri

Heinz Moeri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Systems and methods for deploying patient therapy devices
    Patent number: 10682516
    Abstract: Methods for identifying responders to paresthesia-free stimulation therapy, and associated systems are disclosed. A representative method comprises implanting a pair of spinal cord signal delivery devices and connecting an external signal generator thereto. A plurality of the electrical contacts are simultaneously activated with a high frequency signal without causing paresthesia in the patient, wherein the electrical contacts would cause paresthesia in the patient if activated with a low frequency signal. The high frequency signal is in a range of from about 3 kHz to about 20 kHz and an amplitude of less than 4 mA. If the patient responds favorably, a signal generator is implanted in the patient. A second high frequency signal is then applied to fewer than the plurality of electrical contacts.
    Type: Grant
    Filed: February 17, 2018
    Date of Patent: June 16, 2020
    Assignee: Nevro Corp.
    Inventors: James R. Thacker, Andre B. Walker, Jon Parker, Bradford Evan Gliner, Heinz Moeri
  • Systems and methods for deploying patient therapy devices
    Patent number: 9895538
    Abstract: Methods for identifying responders to paresthesia-free stimulation therapy, and associated systems are disclosed. A representative method comprises implanting a pair of spinal cord signal delivery devices and connecting an external signal generator thereto. A plurality of the electrical contacts are simultaneously activated with a high frequency signal without causing paresthesia in the patient, wherein the electrical contacts would cause paresthesia in the patient if activated with a low frequency signal. The high frequency signal is in a range of from about 3 kHz to about 20 kHz and an amplitude of less than 4 mA. If the patient responds favorably, a signal generator is implanted in the patient. A second high frequency signal is then applied to fewer than the plurality of electrical contacts.
    Type: Grant
    Filed: January 22, 2014
    Date of Patent: February 20, 2018
    Assignee: Nevro Corp.
    Inventors: James R. Thacker, Andre B. Walker, Jon Parker, Bradford Evan Gliner, Heinz Moeri